Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Vaccine|October 30, 2012
Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) induced IgG1 and IgG4 antibody responses in young childrenTetsuo Nakayama, Takuji Kumagai, Ken J Ishii, et al.Intervirology|January 14, 2011
Amino Acid substitutions in matrix, fusion and hemagglutinin proteins of wild measles virus for adaptation to vero cellsJi Yi Xin, Toshiaki Ihara, Katsuhiro Komase, et al.Pediatrics International : Official Journal of the Japan Pediatric Society|February 3, 2015
Reactogenicity and immunogenicity of measles-rubella combined vaccine in school-entry-aged subjects with naturally acquired measles immunityTakuji Kumagai, Toshiaki Ihara, Tetsuo Nakayama, et al.Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|November 4, 2008
[Safety and efficacy in two-dose vaccination using measles and rubella combined (MR) vaccine]Kihei Terada, Kazunobu Ouchi, Toshiaki Ihara, et al.Pediatrics International : Official Journal of the Japan Pediatric Society|May 15, 2009
Quantitative detection of HCMV-DNA in saliva from infants and breast milk on real-time polymerase chain reactionHiroaki Murata, Ritsue Nii, Masahiro Ito, et al.Journal of Virological Methods|April 18, 2006
Rapid detection and typing of influenza A and B by loop-mediated isothermal amplification: comparison with immunochromatography and virus isolationMasahiro Ito, Masahiro Watanabe, Naoko Nakagawa, et al.Vaccine|October 4, 2015
Effect of age on the incidence of aseptic meningitis following immunization with monovalent mumps vaccineHiromi Muta, Takao Nagai, Yuhei Ito, et al.The Pediatric Infectious Disease Journal|December 21, 2016
Laboratory Diagnosis of Breakthrough Varicella in ChildrenMasahiro Watanabe, Hitoshi Ochiai, Masahiro Ito, et al.Emerging Infectious Diseases|March 17, 2016
Cross-Neutralization between Human and African Bat Mumps VirusesHiroshi Katoh, Toru Kubota, Toshiaki Ihara, et al.Vaccine|April 18, 2012
Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productionsTetsuo Nakayama, Yasuyo Kashiwagi, Hisashi Kawashima, et al.Pageof 6